Please assess the completion status of the following clinical trial:

Trial Title: Role of Blood Management in Perioperative Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Anemic patients (defined as Hgb \< 11g/dL within 30 days of initial consult visit)~* Greater than 18-years of age with abnormal uterine bleeding or fibroids~* Scheduled for gynecologic surgery (myomectomy or hysterectomy by laparoscopic, robotic, vaginal or open routes)~Exclusion Criteria:~* Malignancy~* Pregnancy~* Sickle cell anemia or other blood dyscrasias~* Women who received blood transfusions within 30 days prior to surgery~* Women receiving EPO therapy~* Women who have undergone gastric bypass surgery~* Women on therapeutic/full anticoagulation~* Patients undergoing hysteroscopic myomectomy alone without will not be included in the study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Blood mangement group (Type: EXPERIMENTAL): The intervention will include pre-surgical optimization blood management referral based on pre-operative Hgb levels \<11.0 g/dL. Treatment will include PO iron, IV iron, B12 or folate per blood management algorithm.
- Usual care (Type: ACTIVE_COMPARATOR): Usual care per surgeon preference can include iron by mouth or no iron therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).